In vitro and in vivo studies have demonstrated that IL-10+ Bregs induced by mouse tumor cells are able to reduce IFN-γ production by antigen-specific CD8+ and CD4+ T cells as well as NK activation (315, 324). The gene discussed is CD8A; the disease is neoplasm.